IntraPace

Intrapace is developing a new generation of medical devices for the diagnosis and treatment of chronic gastrointestinal disease. The company’s first product is an endoscopically-placed device that targets obesity.

Primary investors include Oxford Bioscience Partners, DFJ ePlanet, Vulcan Capital, Guidant and Johnson & Johnson.